title: Immunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities.
authors.affiliation: Department of Clinical Pharmacology, Genentech Inc, South San Francisco, California, USA.
authors.forename: K M
authors.initials: KM
authors.lastname: Morrissey
authors.affiliation: Clinical Pharmacology, Modeling and Simulation, , Amgen Inc, Thousand Oaks, California, USA.
authors.forename: T M
authors.initials: TM
authors.lastname: Yuraszeck
authors.affiliation: Department of Clinical Pharmacology, Genentech Inc, South San Francisco, California, USA.
authors.forename: C-C
authors.initials: CC
authors.lastname: Li
authors.affiliation: Clinical Pharmacology, Modeling and Simulation, , Amgen Inc, Thousand Oaks, California, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Zhang
authors.affiliation: Clinical Pharmacology, Modeling and Simulation, , Amgen Inc, Thousand Oaks, California, USA.
authors.forename: S
authors.initials: S
authors.lastname: Kasichayanula
mesh_terms: D002986:Clinical Trials as Topic; D017277:Drug Approval; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects; D008495:Medical Oncology; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D012926:Social Control, Formal